Global Protein Expression Systems Market: By Expression System (Yeast Expression, Insect Expression, Cell-Free Expression, Bacterial Expression, Algal Expression, and Mammalian Expression), By Product Type (Systems, Reagents, and Services), By Application (Industrial Proteins, Research, and Therapeutic Proteins), By End User (Biotechnology Companies, Pharmaceutical Companies, Academia, and Clinical Research Organizations), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Protein Expression Systems Market Report Description:
Global protein expression systems market report gives comprehensive outlook on protein expression systems application and usage across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on protein expression systems market gives historical, current, and future market sizes (US$ Mn) on the basis of expression system, product type, application, end user and geographic regions. This report studies protein expression systems market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, protein expression systems market report includes the competition analysis with vividly illustrated the competition dashboard to assess the protein expression systems market competition. Moreover, PBI analyzed protein expression systems market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the protein expression systems market report include manufacturers, marketers, biotechnology companies, pharmaceutical companies, academia, and clinical research organizations, policy makers, and healthcare service providers who are engaged in usage and advocacy of protein expression systems.
Global Protein Expression Systems Market:
Global protein expression systems market was valued around US$ 1,350 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.
COMPETITION ASSESSMENT
Key players profiles in the global protein expression systems market include:
By Expression System
Global protein expression systems market report gives comprehensive outlook on protein expression systems application and usage across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on protein expression systems market gives historical, current, and future market sizes (US$ Mn) on the basis of expression system, product type, application, end user and geographic regions. This report studies protein expression systems market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, protein expression systems market report includes the competition analysis with vividly illustrated the competition dashboard to assess the protein expression systems market competition. Moreover, PBI analyzed protein expression systems market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the protein expression systems market report include manufacturers, marketers, biotechnology companies, pharmaceutical companies, academia, and clinical research organizations, policy makers, and healthcare service providers who are engaged in usage and advocacy of protein expression systems.
Global Protein Expression Systems Market:
Global protein expression systems market was valued around US$ 1,350 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.
COMPETITION ASSESSMENT
Key players profiles in the global protein expression systems market include:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- Becton, Dickinson & Company (U.S.)
- Agilent Technologies, Inc. (U.S.)
- QIAGEN N.V. (Netherlands)
- Takara Bio Inc. (Japan)
- Lonza Group Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- GenScript Biotech Corporation (China)
- Lucigen Corporation (U.S.)
- Synthetic Genomics Inc. (U.S.)
- Promega Corporation (U.S.)
- New England Biolabs, Inc. (U.S.)
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Expression System
- Yeast Expression
- Insect Expression
- Cell-Free Expression
- Bacterial Expression
- Algal Expression
- Mammalian Expression
- Systems
- Reagents
- Services
- Industrial Proteins
- Research
- Therapeutic Proteins
- Biotechnology Companies
- Pharmaceutical Companies
- Academia
- Clinical Research Organizations
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
1. EXECUTIVE SUMMARY
2. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET INTRODUCTION
2.1. Global Protein Expression Systems Market – Taxonomy
2.2. Global Protein Expression Systems Market –Definitions
2.2.1. Expression System Type
2.2.2. Product Type
3. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Protein Expression Systems Market Dynamics – Factors Impact Analysis
3.6. Global Protein Expression Systems Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.7. Global Protein Expression Systems Market – Product Innovations
4. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET, BY EXPRESSION SYSTEMS, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Yeast Expression
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Insect Expression
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Cell-Free Expression
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Bacterial Expression
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Algal Expression
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Mammalian Expression
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
6. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Systems
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Reagents
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
7. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Industrial Proteins
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Research
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Therapeutic Proteins
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
8. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Biotechnology Companies
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical Companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Academia
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Clinical Research Organizations
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
9. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Region, 2017 – 2023
10. NORTH AMERICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Yeast Expression
10.1.1.2. Insect Expression
10.1.1.3. Cell-Free Expression
10.1.1.4. Bacterial Expression
10.1.1.5. Algal Expression
10.1.1.6. Mammalian Expression
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Systems
10.1.2.2. Reagents
10.1.2.3. Services
10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Industrial Proteins
10.1.3.2. Research
10.1.3.3. Therapeutic Proteins
10.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Biotechnology Companies
10.1.4.2. Pharmaceutical Companies
10.1.4.3. Academia
10.1.4.4. Clinical Research Organizations
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
10.1.7. North America Protein Expression Systems Market Dynamics – Trends
11. EUROPE PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Yeast Expression
11.1.1.2. Insect Expression
11.1.1.3. Cell-Free Expression
11.1.1.4. Bacterial Expression
11.1.1.5. Algal Expression
11.1.1.6. Mammalian Expression
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Systems
11.1.2.2. Reagents
11.1.2.3. Services
11.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Industrial Proteins
11.1.3.2. Research
11.1.3.3. Therapeutic Proteins
11.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Biotechnology Companies
11.1.4.2. Pharmaceutical Companies
11.1.4.3. Academia
11.1.4.4. Clinical Research Organizations
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
11.1.7. Europe Protein Expression Systems Market Dynamics – Trends
12. ASIA-PACIFIC PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Yeast Expression
12.1.1.2. Insect Expression
12.1.1.3. Cell-Free Expression
12.1.1.4. Bacterial Expression
12.1.1.5. Algal Expression
12.1.1.6. Mammalian Expression
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Systems
12.1.2.2. Reagents
12.1.2.3. Services
12.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Industrial Proteins
12.1.3.2. Research
12.1.3.3. Therapeutic Proteins
12.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Biotechnology Companies
12.1.4.2. Pharmaceutical Companies
12.1.4.3. Academia
12.1.4.4. Clinical Research Organizations
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
12.1.7. Europe Protein Expression Systems Market Dynamics – Trends
13. LATIN AMERICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Yeast Expression
13.1.1.2. Insect Expression
13.1.1.3. Cell-Free Expression
13.1.1.4. Bacterial Expression
13.1.1.5. Algal Expression
13.1.1.6. Mammalian Expression
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Systems
13.1.2.2. Reagents
13.1.2.3. Services
13.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Industrial Proteins
13.1.3.2. Research
13.1.3.3. Therapeutic Proteins
13.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Biotechnology Companies
13.1.4.2. Pharmaceutical Companies
13.1.4.3. Academia
13.1.4.4. Clinical Research Organizations
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
13.1.7. Latin America Protein Expression Systems Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Yeast Expression
14.1.1.2. Insect Expression
14.1.1.3. Cell-Free Expression
14.1.1.4. Bacterial Expression
14.1.1.5. Algal Expression
14.1.1.6. Mammalian Expression
14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Systems
14.1.2.2. Reagents
14.1.2.3. Services
14.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Industrial Proteins
14.1.3.2. Research
14.1.3.3. Therapeutic Proteins
14.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Biotechnology Companies
14.1.4.2. Pharmaceutical Companies
14.1.4.3. Academia
14.1.4.4. Clinical Research Organizations
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6.n Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
14.1.7. MEA Protein Expression Systems Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Merck KGaA (Germany)
15.2.2. Thermo Fisher Scientific Inc. (U.S.)
15.2.3. Becton, Dickinson & Company (U.S.)
15.2.4. Agilent Technologies, Inc. (U.S.)
15.2.5. QIAGEN N.V. (Netherlands)
15.2.6. Takara Bio Inc. (Japan)
15.2.7. Lonza Group Ltd. (Switzerland)
15.2.8. Bio-Rad Laboratories, Inc. (U.S.)
15.2.9. GenScript Biotech Corporation (China)
15.2.10. Lucigen Corporation (U.S.)
15.2.11. Synthetic Genomics Inc. (U.S.)
15.2.12. Promega Corporation (U.S.)
15.2.13. New England Biolabs, Inc. (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRON
2. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET INTRODUCTION
2.1. Global Protein Expression Systems Market – Taxonomy
2.2. Global Protein Expression Systems Market –Definitions
2.2.1. Expression System Type
2.2.2. Product Type
3. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Protein Expression Systems Market Dynamics – Factors Impact Analysis
3.6. Global Protein Expression Systems Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.7. Global Protein Expression Systems Market – Product Innovations
4. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET, BY EXPRESSION SYSTEMS, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Yeast Expression
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Insect Expression
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Cell-Free Expression
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Bacterial Expression
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Algal Expression
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Mammalian Expression
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
6. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Systems
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Reagents
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
7. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Industrial Proteins
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Research
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Therapeutic Proteins
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
8. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Biotechnology Companies
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical Companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Academia
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Clinical Research Organizations
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
9. GLOBAL PROTEIN EXPRESSION SYSTEMS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Region, 2017 – 2023
10. NORTH AMERICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Yeast Expression
10.1.1.2. Insect Expression
10.1.1.3. Cell-Free Expression
10.1.1.4. Bacterial Expression
10.1.1.5. Algal Expression
10.1.1.6. Mammalian Expression
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Systems
10.1.2.2. Reagents
10.1.2.3. Services
10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Industrial Proteins
10.1.3.2. Research
10.1.3.3. Therapeutic Proteins
10.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Biotechnology Companies
10.1.4.2. Pharmaceutical Companies
10.1.4.3. Academia
10.1.4.4. Clinical Research Organizations
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
10.1.7. North America Protein Expression Systems Market Dynamics – Trends
11. EUROPE PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Yeast Expression
11.1.1.2. Insect Expression
11.1.1.3. Cell-Free Expression
11.1.1.4. Bacterial Expression
11.1.1.5. Algal Expression
11.1.1.6. Mammalian Expression
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Systems
11.1.2.2. Reagents
11.1.2.3. Services
11.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Industrial Proteins
11.1.3.2. Research
11.1.3.3. Therapeutic Proteins
11.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Biotechnology Companies
11.1.4.2. Pharmaceutical Companies
11.1.4.3. Academia
11.1.4.4. Clinical Research Organizations
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
11.1.7. Europe Protein Expression Systems Market Dynamics – Trends
12. ASIA-PACIFIC PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Yeast Expression
12.1.1.2. Insect Expression
12.1.1.3. Cell-Free Expression
12.1.1.4. Bacterial Expression
12.1.1.5. Algal Expression
12.1.1.6. Mammalian Expression
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Systems
12.1.2.2. Reagents
12.1.2.3. Services
12.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Industrial Proteins
12.1.3.2. Research
12.1.3.3. Therapeutic Proteins
12.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Biotechnology Companies
12.1.4.2. Pharmaceutical Companies
12.1.4.3. Academia
12.1.4.4. Clinical Research Organizations
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
12.1.7. Europe Protein Expression Systems Market Dynamics – Trends
13. LATIN AMERICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Yeast Expression
13.1.1.2. Insect Expression
13.1.1.3. Cell-Free Expression
13.1.1.4. Bacterial Expression
13.1.1.5. Algal Expression
13.1.1.6. Mammalian Expression
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Systems
13.1.2.2. Reagents
13.1.2.3. Services
13.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Industrial Proteins
13.1.3.2. Research
13.1.3.3. Therapeutic Proteins
13.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Biotechnology Companies
13.1.4.2. Pharmaceutical Companies
13.1.4.3. Academia
13.1.4.4. Clinical Research Organizations
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Protein Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
13.1.7. Latin America Protein Expression Systems Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Expression Systems Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Yeast Expression
14.1.1.2. Insect Expression
14.1.1.3. Cell-Free Expression
14.1.1.4. Bacterial Expression
14.1.1.5. Algal Expression
14.1.1.6. Mammalian Expression
14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Systems
14.1.2.2. Reagents
14.1.2.3. Services
14.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Industrial Proteins
14.1.3.2. Research
14.1.3.3. Therapeutic Proteins
14.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Biotechnology Companies
14.1.4.2. Pharmaceutical Companies
14.1.4.3. Academia
14.1.4.4. Clinical Research Organizations
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6.n Expression Systems Market - Opportunity Analysis Index, By Expression Systems, Product Type, Application, and Country, 2017 – 2023
14.1.7. MEA Protein Expression Systems Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Merck KGaA (Germany)
15.2.2. Thermo Fisher Scientific Inc. (U.S.)
15.2.3. Becton, Dickinson & Company (U.S.)
15.2.4. Agilent Technologies, Inc. (U.S.)
15.2.5. QIAGEN N.V. (Netherlands)
15.2.6. Takara Bio Inc. (Japan)
15.2.7. Lonza Group Ltd. (Switzerland)
15.2.8. Bio-Rad Laboratories, Inc. (U.S.)
15.2.9. GenScript Biotech Corporation (China)
15.2.10. Lucigen Corporation (U.S.)
15.2.11. Synthetic Genomics Inc. (U.S.)
15.2.12. Promega Corporation (U.S.)
15.2.13. New England Biolabs, Inc. (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRON
